Explore the complete record of transactions filed by Sholehvar David, Président. Insider active across 1 company, notably Neogenomics INC. In total, 1 filings have been logged. History available since 1 April 2022. The latest transaction was disclosed on 1 April 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
David Sholehvar is the President of Clinical Services at Neogenomics Inc. In this role, he oversees the clinical operations of the company, which provides molecular diagnostic services. David is an experienced leader in the healthcare field, contributing to the enhancement of services offered to patients.